✦ LIBER ✦

128 P - Epirubicin intermediate dose plus cyclophosphamide in the treatment of metastatic breast cancer (MBC)

✍ Scribed by G. Trotti; M. Airoldi; G. Reguzzoni; E. Caronno; M.C. Giorgetti; E. Piatto; G. Schieppati

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

TaxolTM (Paclitaxel), epirubicin and cyc

✍ J.-M. Nabholtz; K. Khoo; J.R. Mackey; M. Smylie; T. Al-Tweigeri; D. Dudgeon; O. 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 152 KB

678 - Taxol™ (Paclitaxel), Epirubicin an

✍ J.-M. Nabholtz; K. Khoo; J.R. Mackey; M. Smylie; T Al-Tweigeri; D. Dubgeon; O. K 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 256 KB

Phase II multicentre randomised study of

✍ Bonneterre, J; Dieras, V; Tubiana-Hulin, M; Bougnoux, P; Bonneterre, M-E; Delozi 📂 Article 📅 2004 🏛 Nature Publishing Group 🌐 English ⚖ 120 KB

PP-7-7 Taxol. (paclitaxel), epirubicin a

✍ J.-M. Nabholtz; K. Khoo; T. Al-Tweigeri; M. Smylie; D. Dudgeon; O. Keller; J. Fo 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 175 KB

P92 Docetaxel versus epirubicin/cyclopho

✍ M. Friedrich; C. Wasemann; S. Tauchert; A. Ertan; W. Schmidt; K. Diedrich 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 160 KB

650 - Taxotere™ (docetaxel, D), doxorubi

✍ J.-M. Nabholtz; M. Smyllo; J.R. Mackey; A. Paterson; D. Noel; T. Al-Twelgerl; D. 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 267 KB